H
Henry S. Loeb
Researcher at United States Department of Veterans Affairs
Publications - 91
Citations - 10193
Henry S. Loeb is an academic researcher from United States Department of Veterans Affairs. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 31, co-authored 91 publications receiving 10033 citations. Previous affiliations of Henry S. Loeb include University of Minnesota & Argonne National Laboratory.
Papers
More filters
Journal ArticleDOI
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
Jay N. Cohn,Gary R. Johnson,Susan Ziesche,Frederick R. Cobb,Gary S. Francis,Felix E. Tristani,Raphael F. Smith,W. Bruce Dunkman,Henry S. Loeb,Maylene Wong,Geetha Bhat,Steven Goldman,Ross D. Fletcher,James J. Doherty,C. Vincent Hughes,Peter E. Carson,Guillermo Cintron,Ralph Shabetai,Clair Haakenson +18 more
TL;DR: The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.
Journal ArticleDOI
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Jay N. Cohn,Donald G. Archibald,Susan Ziesche,Joseph A. Franciosa,W. Eugene Harston,Felix E. Tristani,W. Bruce Dunkman,William R. Jacobs,Gary S. Francis,Kathleen H. Flohr,Steven Goldman,Frederick R. Cobb,Pravin M. Shah,Robert S. Saunders,Ross D. Fletcher,Henry S. Loeb,V. Hughes,Bonnie J. Baker +17 more
TL;DR: The data suggest that the addition of hydralazine and isosorbide dinitrate to the therapeutic regimen of digoxin and diuretics in patients with chronic congestive heart failure can have a favorable effect on left ventricular function and mortality.
Journal ArticleDOI
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study
Jay N. Cohn,Donald G. Archibald,Susan Ziesche,Joseph A. Franciosa,W. E. Harston,Felix E. Tristani,W. B. Dunkman,William R. Jacobs,Gary S. Francis,K. H. Flohr,Steven A. Goldman,Frederick R. Cobb,Prediman K. Shah,Robert S. Saunders,Robert H. Fletcher,Henry S. Loeb,V. Hughes,Bonnie J. Baker +17 more
Journal Article
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure
Jay N. Cohn,Gary R. Johnson,R. Shabetai,Henry S. Loeb,Felix E. Tristani,Tom S. Rector,Renee Smith,Robert H. Fletcher +7 more
TL;DR: In this article, the influence of prerandomization measurements on subsequent mortality was examined using data from the Department of Veterans Affairs Cooperative Vasodilator-Heart Failure Trials (V-HeFT I, 641 patients; V-HEFT II, 804 patients).
Journal Article
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group
Jay N. Cohn,Gary R. Johnson,Ralph Shabetai,Henry S. Loeb,Felix E. Tristani,Tom S. Rector,Renee Smith,Robert H. Fletcher +7 more
TL;DR: Optimal assessment of the mortality risk in an individual or a group of individuals with heart failure uses measurement of EF, peak Vo2, CTR, plasma norepinephrine, and the presence of ventricular arrhythmias.